Cochrane Abstracts
Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy (with or without long‐term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Helicobacter Pylori Eradication Therapy Vs. Antisecretory Non‐eradication Therapy (with or Without Long‐term Maintenance Antisecretory Therapy) for the Prevention of Recurrent Bleeding From Peptic Ulcer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431125/all/Helicobacter_pylori_eradication_therapy_vs__antisecretory_non‐eradication_therapy__with_or_without_long‐term_maintenance_antisecretory_therapy__for_the_prevention_of_recurrent_bleeding_from_peptic_ulcer.
Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy (with or without long‐term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431125/all/Helicobacter_pylori_eradication_therapy_vs__antisecretory_non‐eradication_therapy__with_or_without_long‐term_maintenance_antisecretory_therapy__for_the_prevention_of_recurrent_bleeding_from_peptic_ulcer. Accessed December 8, 2024.
Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy (with or without long‐term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431125/all/Helicobacter_pylori_eradication_therapy_vs__antisecretory_non‐eradication_therapy__with_or_without_long‐term_maintenance_antisecretory_therapy__for_the_prevention_of_recurrent_bleeding_from_peptic_ulcer
Helicobacter Pylori Eradication Therapy Vs. Antisecretory Non‐eradication Therapy (with or Without Long‐term Maintenance Antisecretory Therapy) for the Prevention of Recurrent Bleeding From Peptic Ulcer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431125/all/Helicobacter_pylori_eradication_therapy_vs__antisecretory_non‐eradication_therapy__with_or_without_long‐term_maintenance_antisecretory_therapy__for_the_prevention_of_recurrent_bleeding_from_peptic_ulcer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy (with or without long‐term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
ID - 431125
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431125/all/Helicobacter_pylori_eradication_therapy_vs__antisecretory_non‐eradication_therapy__with_or_without_long‐term_maintenance_antisecretory_therapy__for_the_prevention_of_recurrent_bleeding_from_peptic_ulcer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
